Authors:
BARF TA
DEBOER P
WIKSTROM H
PEROUTKA SJ
SVENSSON K
ENNIS MD
GHAZAL NB
MCGUIRE JC
SMITH MW
Citation: Ta. Barf et al., 5-HT1D RECEPTOR AGONIST PROPERTIES OF NOVEL [(TRIFLUOROMETHYL)SULFONYL]OXY]INDOLYL]ETHYLAMINES AND THEIR USE AS SYNTHETIC INTERMEDIATES, Journal of medicinal chemistry, 39(24), 1996, pp. 4717-4726
Authors:
MCCALL RB
ROMERO AG
BIENKOWSKI MJ
HARRIS DW
MCGUIRE JC
PIERCEY MF
SHUCK ME
SMITH MW
SVENSSON KA
SCHREUR PJKD
CARLSSON A
VONVOIGTLANDER PF
Citation: Rb. Mccall et al., CHARACTERIZATION OF U-92016A AS A SELECTIVE, ORALLY-ACTIVE, HIGH INTRINSIC ACTIVITY 5-HYDROXYTRYPTAMINE(1A) AGONIST, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 875-883
Authors:
KRZESICKI RF
HATFIELD CA
BIENKOWSKI MJ
MCGUIRE JC
WINTERROWD GE
CHAPMAN DL
BERGER AE
MCEWAN RN
CARTER DB
CHOSAY JG
TRACEY DE
CHIN JE
Citation: Rf. Krzesicki et al., REGULATION OF EXPRESSION OF IL-1 RECEPTOR ANTAGONIST PROTEIN IN HUMANSYNOVIAL AND DERMAL FIBROBLASTS, The Journal of immunology, 150(9), 1993, pp. 4008-4018